Last reviewed · How we verify
Baofeikang Granule — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Baofeikang Granule (Baofeikang Granule) — Beijing Municipal Science & Technology Commission.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Baofeikang Granule TARGET | Baofeikang Granule | Beijing Municipal Science & Technology Commission | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Baofeikang Granule CI watch — RSS
- Baofeikang Granule CI watch — Atom
- Baofeikang Granule CI watch — JSON
- Baofeikang Granule alone — RSS
Cite this brief
Drug Landscape (2026). Baofeikang Granule — Competitive Intelligence Brief. https://druglandscape.com/ci/baofeikang-granule. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab